Alpharma Inc. , a specialty pharmaceutical company with global leadership positions in products for humans and animals, today announced that it intends to significantly expand its worldwide presence in animal pharmaceuticals with the acquisition of the Medicated Feed Additive (MFA) business of Roche for approximately $300 million.